openPR Logo
Press release

Radiopharmaceuticals Market Exclusive Trends Analysis with Forecast to 2034

Radiopharmaceuticals Market Exclusive Trends Analysis with

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radiopharmaceuticals Market - (By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Leutetium 177, Yttrium 90, Gallium 67, Gallium 68, Rubidium 82, Iodine 123, Iodine 125, Indium 111 and Other Isotopes), By Indication (Oncology, Cardiology, Gastoenterology, Neuroendocrinology, Neurology, Nephrology and Other Indications), By Source (Cyclotrons, Nuclear Reactors and Other Sources), By Type (Diagnostic and Therapeutic), By End User (Hospitals, Medical Imaging Centers, Cancer Research Institute and Other End Users)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global Radiopharmaceuticals Market Size is valued at USD 6.2 Billion in 2024 and is predicted to reach USD 19.6 Billion by the year 2034 at a 12.7% CAGR during the forecast period for 2025-2034.

Radiopharmaceuticals are radioactive isotope-based compounds used in medical imaging and therapy, particularly for diagnosing and treating cancer, cardiovascular diseases, and neurological disorders. These compounds help visualize organs and tissues through advanced imaging technologies, enabling accurate diagnosis and targeted treatment.

Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2290

List of Prominent Players in the Radiopharmaceuticals Market:
• Bayer
• Cardinal Health
• Curium Pharma
• Eli Lilly
• General Electric Company
• Iso-Tex Diagnostics
• LANTHEUS HOLDINGS, INC
• Novartis
• Siemens
• Bracco Imaging S.P.A.
• Pharmalogic Holdings Corp
• Eczacibasi-Monrol Nuclear Products
• NTP Radioisotopes Soc Ltd.
• Nordion Inc.
• Advanced Accelerator Applications (A Novartis Company)
• 2 Northstar Medical Radioisotopes
• Eckert & Ziegler
• Isotope JSC
• Jubilant Draximage, Inc. (A Subsidiary Of Jubilant Pharma)
• Global Medical Solutions
• Shine Technologies, Llc
• Isotopia Molecular Imaging Ltd.
• Bwxt Medical Ltd.
• Institute Of Isotopes
• China Isotope & Radiation Corporation
• Yantai Dongcheng Pharmaceutical Group Co., Ltd.
• Cyclopharm
• Ire Elit
• Others

Market Dynamics:
Drivers-
The demand for radiopharmaceuticals is increasing due to their high efficiency and non-invasive nature, making them a preferred choice in medical imaging and therapy. The rising prevalence of chronic diseases, especially cancer, is a significant factor fueling market expansion. Additionally, advancements in diagnostic and therapeutic tools are enhancing the effectiveness of nuclear medicine, driving further growth. Industry players are also contributing to revenue expansion through new product launches, mergers, and strategic collaborations.

Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2290

Challenges:
Regulatory Barriers: Stringent approval processes and compliance requirements pose challenges for market players, slowing down the introduction of new radiopharmaceuticals.
Shortage of Skilled Professionals: The field requires highly trained specialists, and the limited availability of skilled personnel, particularly in emerging markets, is a concern. Supply Chain Disruptions: The COVID-19 pandemic led to significant production and distribution challenges, causing shortages in radiopharmaceutical supplies.

Regional Trends:
North America is expected to hold a dominant market share due to increased R&D investments and a rising number of cancer cases requiring radiopharmaceutical-based treatments. Asia Pacific is witnessing substantial growth, driven by technological advancements, improved healthcare infrastructure, and increased adoption of nuclear medicine. The growing demand for targeted cancer therapies and accelerated drug development are also contributing to market expansion in the region.

Recent Developments:
• In Nov 2023, Ionetix Corporation entered into a supply deal with Bayer for the medicinal radioisotope actinium-225 (Ac-225). Ionetix will supply Bayer with high-purity, non-carrier added (n.c.a.) Ac-225
• In June 2023, Jubilant Draximage Inc. and Evergreen Theragnostics, Inc. have entered into a new arrangement. Under this agreement, Jubilant's radiopharmacy business will be responsible for the preparation, sale, and distribution of OCTEVYTM (Kit for Preparation of Ga 68 DOTATOC Injection) doses to positron emission tomography (PET) customers throughout the United States.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2290

Segmentation of Radiopharmaceuticals Market-
By Radioisotope-
• Technetium 99
• Fluorine 18
• Iodine 131
• Leutetium 177
• Yttrium 90
• Gallium 67
• Gallium 68
• Rubidium 82
• Iodine 123
• Iodine 125
• Indium 111
• Other Isotopes
By Indication-
• Oncology
• Cardiology
• Gastoenterology
• Neuroendocrinology
• Neurology
• Nephrology
• Other Indications
By Source-
• Cyclotrons
• Nuclear Reactors
• Other Sources
By Type-
• Diagnostic
• Therapeutic
By End User-
• Hospitals
• Medical Imaging Centers
• Cancer Research Institute
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Get more information: @
https://www.insightaceanalytic.com/report/radiopharmaceuticals-market/2290

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Exclusive Trends Analysis with Forecast to 2034 here

News-ID: 3933531 • Views:

More Releases from Insightace Analytic Pvt Ltd.

3D Printing Construction Market Top Companies Study - COBOD International A/S; Yingchuang Building Technique (Shanghai) Co.Ltd.(Winsun); XtreeE; Apis Cor; WASP S.r.I.
3D Printing Construction Market Top Companies Study - COBOD International A/S; Y …
"3D Printing Construction Market" in terms of revenue was estimated to be worth USD 11.9 Billion in 2024 and is poised to reach USD 1,231.6 Billion by the year 2034, growing at a CAGR of 59.2% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1604 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global 3D
Digital Twin Market Forecast Indicates Robust Demand for Predictive Maintenance and Operational Optimization
Digital Twin Market Forecast Indicates Robust Demand for Predictive Maintenance …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Twin Market Size, Share & Trends Analysis Report By Type (System Digital Twin, Product Digital Twin, Process Digital Twin), Application Area (Business Optimization, Predictive Maintenance, Production Design and Development, Others), Industry (Aerospace & Defense, Automotive & Transportation, Home & Commercial, Healthcare, Energy & Utilities, Oil & Gas, Agriculture, Telecommunication, Others)- Market Outlook And Industry
E-Commerce Logistics Market Insights Show Increasing Adoption of Automated Warehousing and Fulfillment Centers
E-Commerce Logistics Market Insights Show Increasing Adoption of Automated Wareh …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034" The global e-commerce logistics market is estimated to reach over USD 5340.2 Billion by the year 2034, exhibiting a CAGR of 26.4% during the forecast period. Get Free Access
E-Bike Battery Pack Market Expansion Driven by Rising Popularity of Pedelecs and Electric Two-Wheelers in Urban Areas
E-Bike Battery Pack Market Expansion Driven by Rising Popularity of Pedelecs and …
The global e-bike battery pack market is estimated to reach over USD 45.1 Billion by the year 2034, exhibiting a CAGR of 15.2% during the forecast period. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1594 An e-bike battery pack functions as a rechargeable power source designed to drive the electric motor of an electric bicycle, enabling propulsion with reduced or no pedaling effort. These battery systems are available

All 5 Releases


More Releases for Radiopharmaceuticals

Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842 This latest report researches the industry structure, sales, revenue, price and
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a